118 related articles for article (PubMed ID: 26767798)
1. Plasma levels of intermedin (adrenomedullin-2) in healthy human volunteers and patients with heart failure.
Bell D; Gordon BJ; Lavery A; Megaw K; Kinney MO; Harbinson MT
Peptides; 2016 Feb; 76():19-29. PubMed ID: 26767798
[TBL] [Abstract][Full Text] [Related]
2. Adrenomedullin and intermedin gene transcription is increased in leukocytes of patients with chronic heart failure at different stages of the disease.
Cabiati M; Sabatino L; Svezia B; Caruso R; Verde A; Caselli C; Prescimone T; Giannessi D; Del Ry DR
Peptides; 2014 May; 55():13-6. PubMed ID: 24531032
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of intermedin on cardiovascular, pulmonary and renal diseases: comparison with adrenomedullin and CGRP.
Holmes D; Campbell M; Harbinson M; Bell D
Curr Protein Pept Sci; 2013 Jun; 14(4):294-329. PubMed ID: 23745696
[TBL] [Abstract][Full Text] [Related]
4. Plasma intermedin levels in patients with acute myocardial infarction.
Lv Z; Wu K; Chen X; Zhang X; Hong B
Peptides; 2013 May; 43():121-5. PubMed ID: 23499766
[TBL] [Abstract][Full Text] [Related]
5. Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels.
Etoh T; Kato J; Takenaga M; Imamura T; Kitamura K; Koiwaya Y; Eto T
Clin Cardiol; 1999 Feb; 22(2):113-7. PubMed ID: 10068849
[TBL] [Abstract][Full Text] [Related]
6. Plasma adrenomedullin concentration in patients with heart failure.
Kato J; Kobayashi K; Etoh T; Tanaka M; Kitamura K; Imamura T; Koiwaya Y; Kangawa K; Eto T
J Clin Endocrinol Metab; 1996 Jan; 81(1):180-3. PubMed ID: 8550749
[TBL] [Abstract][Full Text] [Related]
7. Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems.
Bell D; McDermott BJ
Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S247-62. PubMed ID: 17965749
[TBL] [Abstract][Full Text] [Related]
8. High levels of circulating adrenomedullin in severe illness: correlation with C-reactive protein and evidence against the adrenal medulla as site of origin.
Ehlenz K; Koch B; Preuss P; Simon B; Koop I; Lang RE
Exp Clin Endocrinol Diabetes; 1997; 105(3):156-62. PubMed ID: 9228512
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma levels of adrenomedullin in patients with heart failure.
Nishikimi T; Saito Y; Kitamura K; Ishimitsu T; Eto T; Kangawa K; Matsuo H; Omae T; Matsuoka H
J Am Coll Cardiol; 1995 Nov; 26(6):1424-31. PubMed ID: 7594065
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of adrenomedullin 2/intermedin in rat hearts with congestive heart failure.
Hirose T; Totsune K; Mori N; Morimoto R; Hashimoto M; Nakashige Y; Metoki H; Asayama K; Kikuya M; Ohkubo T; Hashimoto J; Sasano H; Kohzuki M; Takahashi K; Imai Y
Eur J Heart Fail; 2008 Sep; 10(9):840-9. PubMed ID: 18692436
[TBL] [Abstract][Full Text] [Related]
11. Changes of plasma adrenomedullin and proadrenomedullin N-terminal 20 peptide concentrations in patients with heart failure.
Gao YQ; Li ZL; Wu HC; Tang CS; Zhong P; Lu Q; Yan QN
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):632-4. PubMed ID: 12376296
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of calcitonin gene-related peptide (CGRP) related peptides (CGRP, amylin, adrenomedullin and adrenomedullin-2/intermedin) in goldfish (Carassius auratus): cloning and distribution.
Martínez-Alvarez RM; Volkoff H; Cueto JA; Delgado MJ
Peptides; 2008 Sep; 29(9):1534-43. PubMed ID: 18539360
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-derived intermedin/adrenomedullin-2 protects human ventricular cardiomyocytes from ischaemia-reoxygenation injury predominantly via the AM₁ receptor.
Bell D; Campbell M; McAleer SF; Ferguson M; Donaghy L; Harbinson MT
Peptides; 2016 Feb; 76():1-13. PubMed ID: 26743504
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma levels of intermedin and brain natriuretic peptide associated with severity of coronary stenosis in acute coronary syndrome.
Qin YW; Teng X; He JQ; Du J; Tang CS; Qi YF
Peptides; 2013 Apr; 42():84-8. PubMed ID: 23391507
[TBL] [Abstract][Full Text] [Related]
15. Effects of intermedin(1-53) on cardiac function and ischemia/reperfusion injury in isolated rat hearts.
Yang JH; Jia YX; Pan CS; Zhao J; Ouyang M; Yang J; Chang JK; Tang CS; Qi YF
Biochem Biophys Res Commun; 2005 Feb; 327(3):713-9. PubMed ID: 15649405
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical localization of adrenomedullin 2/intermedin-like immunoreactivity in human hypothalamus, heart and kidney.
Takahashi K; Kikuchi K; Maruyama Y; Urabe T; Nakajima K; Sasano H; Imai Y; Murakami O; Totsune K
Peptides; 2006 Jun; 27(6):1383-9. PubMed ID: 16359754
[TBL] [Abstract][Full Text] [Related]
17. Expression of adrenomedullin2/intermedin in human brain, heart, and kidney.
Morimoto R; Satoh F; Murakami O; Totsune K; Suzuki T; Sasano H; Ito S; Takahashi K
Peptides; 2007 May; 28(5):1095-103. PubMed ID: 17346853
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin as a Biomarker of Heart Failure.
Nishikimi T; Nakagawa Y
Heart Fail Clin; 2018 Jan; 14(1):49-55. PubMed ID: 29153200
[TBL] [Abstract][Full Text] [Related]
19. Intermedin (adrenomedullin-2) enhances cardiac contractile function via a protein kinase C- and protein kinase A-dependent pathway in murine ventricular myocytes.
Dong F; Taylor MM; Samson WK; Ren J
J Appl Physiol (1985); 2006 Sep; 101(3):778-84. PubMed ID: 16763098
[TBL] [Abstract][Full Text] [Related]
20. Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failure.
Self WH; Storrow AB; Hartmann O; Barrett TW; Fermann GJ; Maisel AS; Struck J; Bergmann A; Collins SP
Am J Emerg Med; 2016 Feb; 34(2):257-62. PubMed ID: 26577429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
